How does a single cell reliably build one of the most complex structures known in nature? New research suggests the answer ...

Solar cell maker Jupiter International Limited on Wednesday said it has commissioned its third solar cell manufacturing unit in Himachal Pradesh’s Baddi. This marked a significant leap in ...

Growing a restaurant group in New York isn’t just about finding the next great location or perfecting your menu. It’s about building a legal foundation that protects what you’ve already built while ...

The Walt Disney Company is overhauling its marketing organization and appointing Asad Ayaz, previously chief brand officer, as chief marketing and brand officer to lead the division, according to a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Weight loss remains a hot area ...

Optical metasurfaces, with their ultra-thin and lightweight properties, are driving the miniaturization and planarization of optical systems. However, their development from unit-cell design to system ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia. The discovery, ...

CSL Seqirus, the vaccine unit of Australian biotech CSL, has signed a pact to provide Saudi Arabia with cell-based influenza shots and help establish its production in-country. The move forms part of ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Before cells can divide by mitosis, they first need to replicate all of their chromosomes, so that each of the daughter cells can receive a full set of genetic material. Scientists have until now ...

(Reuters) -Novo Nordisk has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday. Bloomberg News first reported on ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...